Shares of clinical nutrition and diagnostics company Guardion Health Sciences, Inc. (NASDAQ: GHSI) rose 4.89% to $2.79 in premarket trading. Guardion stock has gained 2.70 percent in the last five sessions; nonetheless, it has lost -43.23% in the last month.
GHSI stock has soared 69.92% over the last three months, but has rise 6.83 percent since beginning of the year. The price of GHSI stock jumped today in pre-market trading after news of financial results was announced by Guardion.
How GHSI performed?
Health care professionals, patients, and consumers can achieve their health goals using Guardion’s expertise in clinical nutrition, medical foods, and diagnostics. In addition to its commercial and development initiatives, Guardion also has a scientific and medical advisory board, headed by seasoned medical executives, with years of experience.
Financial results for the three-month period and the year ended December 31, 2020 were announced by Guardion today.
A reverse split of the Company’s outstanding common stock in the ratio of 1 for 6 shall become effective March 1, 2021. In light of the reverse stock split, all share and per share amounts included herein have been adjusted retroactively to avoid double counting. Following are some financial highlights for the year ending December 31, 2020:
- Increase of approximately 109% in revenue of $1,889,844 during the fiscal year 2020 was generated compared to $902,937 of revenue generated in 2019.
- Loss of $(8,571,657) or $(0.60) per share for the year ended December 31, 2020, was recorded compared with a loss of $(10,878,308) or $(1.79) per share for the prior year.
- There was $8,518,732 in cash at December 31, 2020.
- After adjusting for the sale of GHSI common stock and warrant exercises in January and February 2020, pro forma cash balance at Guardion Health (GHSI) on December 31, 2020 was $45,727,241.